Florence Meyer-Losic

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Dendritic Cells

Cross Sectional

Combination Therapy

Top Venues

Cancer research communications

Pharmaceuticals (Basel, Switzerland)

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Hélène Savel, Sandrine Barbier, Cécile Proust-Lima, Virginie Rondeau, Rodolphe Thiebaut, Florence Meyer-Losic, Laura Richert
On the Choice of Longitudinal Models for the Analysis of Antitumor Efficacy in Mouse Clinical Trials of Patient-derived Xenograft Models. Cancer research communications 3 (1) (2023)
Hélène Savel, Sandrine Barbier, Cécile Proust-Lima, Virginie Rondeau, Rodolphe Thiebaut, Florence Meyer-Losic, Laura Richert
On the Choice of Longitudinal Models for the Analysis of Antitumor Efficacy in Mouse Clinical Trials of Patient-derived Xenograft Models. Cancer research communications 3 (1) (2023)
Pascale Plas, Lorenzo Limana, Denis Carré, Amath Thiongane, Olivier Raguin, Rosalba Mansi, Florence Meyer-Losic, Stéphane Lezmi
Comparison of the Anti-Tumour Activity of the Somatostatin Receptor (SST) Antagonist [ 177 Lu]Lu-Satoreotide Tetraxetan and the Agonist [ 177 Lu]Lu-DOTA-TATE in Mice Bearing AR42J SST 2 -Positive Tumours. Pharmaceuticals (Basel, Switzerland) 15 (9) (2022)
Niranjan Awasthi, Margaret A Schwarz, Changhua Zhang, Stephan G Klinz, Florence Meyer-Losic, Benjamin Beaufils, Arunthathi Thiagalingam, Roderich E Schwarz
Augmenting Experimental Gastric Cancer Activity of Irinotecan through Liposomal Formulation and Antiangiogenic Combination Therapy. Molecular cancer therapeutics 21 (7) (2022)